Named after | Massachusetts General Hospital and Brigham and Women's Hospital |
---|---|
Formation | 1994 |
Type | Non-profit organization |
Headquarters | 399 Revolution Drive Somerville, Massachusetts, U.S. |
Coordinates | 42°20′51″N71°04′55″W / 42.347414°N 71.081904°W |
Services | Healthcare |
President & CEO | Anne Klibanski |
Margaret S. Norton | |
Affiliations | Harvard University |
Revenue (2022, Ending September 30) | $18 billion |
Staff (2023) | ~82,000 |
Website | massgeneralbrigham |
Formerly called | Partners HealthCare (1994–2020) |
[1] [2] [3] [4] |
Mass General Brigham (MGB) is a not-for-profit, [5] integrated health care system [6] that engages in medical research, [7] teaching, [8] and patient care. It is the largest hospital-based research enterprise in the United States, with annual funding of more than $2 billion. [9] The system's annual revenue was nearly $18 billion in 2022. [10] It is also an educational institution, founded by Brigham and Women's Hospital and Massachusetts General Hospital. [11] [12] [13] The system provides clinical care through two academic hospitals, three specialty hospitals, seven community hospitals, home care services, a health insurance plan, and a robust network of specialty practices, urgent care facilities, and outpatient clinics/surgical centers. It is the largest private employer in Massachusetts. [14] In 2023, the system reported that from 2017–2021 its overall economic impact was $53.4 billion – more than the annual state budget. [15]
Mass General Brigham was founded by the academic medical centers (AMCs) which give it its name: Massachusetts General Hospital (colloquially referred to as "Mass General") and Brigham and Women's Hospital ("the Brigham"). Both hospitals were founded in the early 1800s, are based in Boston, and serve as major teaching hospitals of Harvard Medical School. [16]
In 1994, fueled by economic and political pressure to cut costs on patient care and health care education, the two hospitals merged to create a new parent corporation: Partners Healthcare. [17] The two entities continued to operate largely independently, and remained competitors in multiple areas, until 2019. [18] [19]
In 2015, Partners launched an electronic health record (EHR) system, allowing doctors, nurses, and other caregivers easier access patients' medical history. The effort computerized millions of health records across the system, creating one record for each Partners patient, allowing information to be more easily shared among caregivers. [20]
In 2016, the system moved to into their current headquarters, located in Somerville's Assembly Row. The building allowed Mass General Brigham to merge 14 other offices. [21] [22]
In 2019, 25 years after the founding of Partners, the health system made the decision to fully integrate the organization under the new name "Mass General Brigham". [23]
Mass General Brigham has 2.5 million patients annually, generating $18 billion in operating revenue and more than $2 billion in research funding. Brigham and Women's and Massachusetts General are consistently ranked among the best hospitals in America, [24] while Massachusetts Eye and Ear, [25] McLean, [26] and Spaulding [27] are also among the nation's best in their respective specialties.
Its current President and CEO is Dr. Anne Klibanski. [28]
The system's current Board of Directors consists of the following members: [29]
Executive Committee of the Board
Board Members
Current members of Mass General Brigham include:
There are at least 22 Nobel Prize winners affiliated with Mass General Brigham institutions. [65] [66]
The following is a lists of medical firsts and milestones accomplished by Mass General Brigham institutions: [67] [68]
Mass General Brigham is the largest hospital system-based research enterprise in America, with an annual research budget exceeding $2 billion. It is the top system for National Institutes of Health (NIH) funding in the world, receiving $1.04 billion from NIH in 2022.
The system's funding for research has grown from $1.5 bilion in 2012 to $2.3 billion in 2023, with nearly 2/3 of the funds coming from outside of Massachusetts. Research revenues in 2022 were $2.2 billion. In 2023, the system said it had over 2,700 ongoing clinical trials, focused on accelerating new treatments and therapies. Among the system's recent innovations: Visudyne for macular degeneration, Enbrel for rheumatoid arthritis, Eloctate and Alprolix for hemophilia, Entyvio for crohn's disease, and total joint replacements such as Durasul, Longevity, E1, and Vicacit-E. [15]
In May 2000, CEO Dr. Samuel Thier and William C. Van Faasen, CEO of Blue Cross Blue Shield of Massachusetts—the state's biggest health insurer—agreed to a deal that raised insurance costs all across Massachusetts. [69] They agreed that Van Faasen would substantially increase insurance payments to Mass General Brigham doctors and hospitals, largely correcting the underpayments of the previous 10 years. However, Partners issued a statement saying that Thier pledged only that he would treat all insurers equally. [13] According to Boston Globe investigative journalists, Blue Cross and other insurers increased the rate they paid Mass General Brigham by 75 percent between 2000 and 2008, though CEO James J. Mongan argued insurance rates in Massachusetts have gone up at roughly the same rate as the national average. [13] [70]
In 2013, Mass General Brigham's plan to take over 378-bed South Shore Hospital in Weymouth was reviewed due to fears that the expansion plan is anticompetitive, a conduct Mass General Brigham had been accused of over the past four years in other cases. [71] [72] In 2015, the system abandoned their plans to invest $200 million into the hospital. [73]
In April 2017, the United States District Court for the District of Massachusetts announced that Partners HealthCare System and one of its hospitals, Brigham and Women's Hospital, agreed to pay a $10 million fine to resolve allegations that a stem cell research lab fraudulently obtained federal grant funding. Federal prosecutors commended the Brigham for disclosing allegations of fraudulent research at the lab and for taking steps to prevent future recurrences of such conduct. [74]
In May 2017, Partners announced they would be cutting more than $600 million in expenses over the next three years in an effort to control higher costs and to become more efficient. The cost-cutting initiative was called Partners 2.0, and the plan looked to reduce costs in research, care delivery, revenue collection, and supply chain. The plan began on October 1, 2017 and eliminated jobs. The company lost $108 million in 2016, [1] but was profitable in 2017 despite industry turmoil. [75]
In February 2018, Partners announced that 100 coders would have their jobs outsourced to India in a cost saving move. This was all part of the non-profit hospital and physicians network's three-year plan to reduce $500 million to $800 million in overhead costs. CEO Dr. David Torchiana said the job cuts were a financial necessity, adding that most sectors outsource call centers and back-office functions. [4]
During the SARS-CoV-2 pandemic, Partners HealthCare, who reported operating income of $484 million (3.5% operating margin) in fiscal year 2019, [76] refused hazard pay to its healthcare workers despite lack of proper PPE. However, they did not layoff or furlough any employees during the pandemic, while cutting executive salaries. [77] The system explained it does not calibrate pay and benefits based upon patients' conditions, because a core part of its mission is delivering the same high-quality care to all patients regardless of the severity of their condition. Partners also provided employees with pay and benefits for those unable to work due to COVID-related illness, eight weeks of pay for those temporarily without work, and hotel rooms for employees. [73]
Mass General Brigham reported a loss of operations of $432 million (−2.6% operating margin) in fiscal year 2022 due to historic cost inflation, significant workforce shortages, and a worsening capacity crisis. Many health care systems and hospitals nationwide are experiencing the worst year financially since the start of the COVID-19 pandemic. In response, the system announced its plan for a long-term sustainable future, which includes the following initiatives: Advancing integration to improve patient care and identify efficiencies, addressing the labor shortage by building workforce pipelines, and reducing expenses. [78] [79]
Harvard Medical School (HMS) is the medical school of Harvard University and is located in the Longwood Medical Area in Boston, Massachusetts. Founded in 1782, HMS is one of the oldest medical schools in the United States, and provides patient care, medical education, and research training through its 15 clinical affiliates and research institutes, including Massachusetts General Hospital (MGH), Boston Children's Hospital, Dana–Farber Cancer Institute, Brigham and Women's Hospital, Beth Israel Deaconess Medical Center, Mount Auburn Hospital, McLean Hospital, Cambridge Health Alliance, The Baker Center for Children and Families, Spaulding Rehabilitation Hospital, and others
Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts is a teaching hospital of Harvard Medical School and one of the founding members of Beth Israel Lahey Health. It was formed out of the 1996 merger of Beth Israel Hospital and New England Deaconess Hospital. Among independent teaching hospitals, Beth Israel Deaconess Medical Center has ranked in the top three recipients of biomedical research funding from the National Institutes of Health. Research funding totals nearly $200 million annually. BIDMC researchers run more than 850 active sponsored projects and 200 clinical trials. The Harvard-Thorndike General Clinical Research Center, the oldest clinical research laboratory in the United States, has been located on this site since 1973.
Massachusetts General Hospital is a teaching hospital located in the West End neighborhood of Boston, Massachusetts. It is the original and largest clinical education and research facility of Harvard Medical School/Harvard University, and houses the world's largest hospital-based research program with an annual research budget of more than $1.2 billion in 2021. It is the third-oldest general hospital in the United States with a patient capacity of 999 beds. Along with Brigham and Women's Hospital, Mass General is a founding member of Mass General Brigham, formerly known as Partners HealthCare, the largest healthcare provider in Massachusetts.
Brigham and Women's Hospital is the second largest teaching hospital of Harvard Medical School and the largest hospital in the Longwood Medical Area in Boston, Massachusetts. Along with Massachusetts General Hospital, it is one of the two founding members of Mass General Brigham, the largest healthcare provider in Massachusetts. Giles Boland, MD, serves as the hospital's current president.
Cathy E. Minehan was President and Chief Executive Officer of the Federal Reserve Bank of Boston from 1994 until her retirement in July 2007. Minehan also served as a member of the Federal Open Market Committee, the body responsible for U.S. monetary policy. She was "appointed Dean of the School of Management of Simmons College, a private university, in August 2011 and is Managing Director of Arlington Advisory Partners, a private advisory services firm."
Dana-Farber Cancer Institute (DFCI) is a comprehensive cancer treatment and research center in Boston, Massachusetts. Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.
Massachusetts Eye and Ear is a specialty hospital located in Boston, Massachusetts, United States, which focuses on ophthalmology (eye), otolaryngology (ear/nose/throat), and related medicine and research. Founded in 1824 as the Boston Eye Infirmary (BEI), it has also been known as the Massachusetts Charitable Eye and Ear Infirmary (MCEEI) and Massachusetts Eye and Ear Infirmary (MEEI). It is a teaching partner of Harvard Medical School.
The Lahey Hospital & Medical Center, formerly known as the Lahey Clinic, is a physician-led nonprofit teaching hospital of Tufts University School of Medicine based in Burlington, Massachusetts. The hospital was founded in Boston in 1923 by surgeon Frank H. Lahey, M.D., and is managed by Beth Israel Lahey Health. U.S. News & World Report has cited it several times on its list of "America's Best Hospitals" in the category of urology.
Samuel Osiah Thier was professor of Medicine and Health Care Policy at Harvard University. He earned his medical degree at the State University of New York Upstate Medical University in 1960. He previously served as the president of Brandeis University from 1991–1994 and the president of the Massachusetts General Hospital from 1994-96.
Tufts Medical Center, a 15-building campus located in Boston, Massachusetts, is a downtown Boston hospital midway between Chinatown and the Boston Theater District.
Newton-Wellesley Hospital (NWH) is a community teaching medical center located in Newton, Massachusetts on Washington Street. It is affiliated with Tufts University School of Medicine and Harvard Medical School. Founded in 1881, part of its campus is listed on the National Register of Historic Places as the Newton Cottage Hospital Historic District.
John Hartwell Harrison was an American urologic surgeon, professor, and author. He performed the first human organ removal for transplant to another. This was a pivotal undertaking as a member of the medical team that accomplished the world’s first successful kidney transplant. The team conducted its landmark transplant between identical twins in 1954.
Gary L. Gottlieb, is a prominent psychiatrist, healthcare executive and healthcare investor who served as CEO of Partners in Health from 2015-2019.
Ferenc Andras Jolesz was a Hungarian-American physician and scientist best known for his research on image guided therapy, the process by which information derived from diagnostic imaging is used to improve the localization and targeting of diseased tissue to monitor and control treatment during surgical and interventional procedures. He pioneered the field of Magnetic Resonance Imaging-guided interventions and introduced of a variety of new medical procedures based on novel combinations of imaging and therapy delivery.
David F. M. Brown is an American physician, emergency medicine specialist, teacher, researcher, and administrator. He is the MGH Trustees Endowed Professor of Emergency Medicine at Harvard Medical School and served as Chief of the Department of Emergency Medicine at Massachusetts General Hospital. from 2013-2021 when he became President of Massachusetts General Hospital. In 2024, his role was expanded to President, Academic Medical Centers, Mass General Brigham, overseeing both Massachusetts General and Brigham and Women’s Hospitals.
Daniel David Federman, was an American endocrinologist and the Carl W. Walter Distinguished Professor of Medicine and the dean for medical education at Harvard Medical School. He helped change medical education at through its New Pathway curriculum around the early 1990s, and his work helped create the field of genetic endocrinology. Federman also worked for over thirty years at Boston's Brigham and Women's Hospital, a Harvard Medical School teaching hospital in the Longwood Medical and Academic Area.
Cooley Dickinson Hospital is a nonprofit community hospital located in Northampton, Massachusetts. It is the primary hub of Cooley Dickinson Health Care, a regional network of primary and specialty care medical providers, an affiliate of Massachusetts General Hospital, which is part of Mass General Brigham.
Reshma Kewalramani, is the president and chief executive officer of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts, as of April 1, 2020. She is the first female CEO of a large US biotech company. She was previously the chief medical officer and vice president of global medicines development and medical affairs at Vertex.
Ali S. Raja is an American emergency physician and researcher. He is the Executive Vice Chair of the Department of Emergency Medicine at Massachusetts General Hospital, and a professor at Harvard Medical School.
Beth Israel Lahey Health (BILH) is a non-profit integrated health system based in Massachusetts, with locations in New Hampshire. Formed through the 2019 merger of two large Massachusetts health systems led by Beth Israel Deaconess Medical Center and Lahey Hospital & Medical Center, it is the largest health system in Massachusetts by count of hospitals, with 10 acute-care hospitals in the state.